Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-09-020047
Filing Date
2009-03-25
Accepted
2009-03-25 17:15:56
Documents
6
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a09-8300_110k.htm 10-K 1763097
2 EX-10.16 a09-8300_1ex10d16.htm EX-10.16 27575
3 EX-10.17 a09-8300_1ex10d17.htm EX-10.17 15457
4 EX-31.1 a09-8300_1ex31d1.htm EX-31.1 12540
5 EX-31.2 a09-8300_1ex31d2.htm EX-31.2 12945
6 EX-32.1 a09-8300_1ex32d1.htm EX-32.1 8656
  Complete submission text file 0001104659-09-020047.txt   1841805
Mailing Address 1444 WAZEE STREET SUITE 210 DENVER CO 80202
Business Address 1444 WAZEE STREET SUITE 210 DENVER CO 80202 7209466440
CERAGENIX PHARMACEUTICALS, INC. (Filer) CIK: 0001180743 (see all company filings)

EIN.: 841561463 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-50470 | Film No.: 09704686
SIC: 3841 Surgical & Medical Instruments & Apparatus